Absorption of orally administered neomycin and kanamycin, with special reference to patients with severe hepatic and renal diseases.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D007612:Kanamycin; D007674:Kidney Diseases / Q000502:physiology*; D008107:Liver Diseases / Q000502:physiology*; D009355:Neomycin / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D007612:Kanamycin; D009355:Neomycin
ANTIBIOTICS/pharmacology; KIDNEY DISEASES/physiology; LIVER DISEASES/physiology; NEOMYCIN/pharmacology